Belgium's UCB to sell China neurology, allergy business for $680 million | Republic Business

Advertisement

Republic Business

Google app bug that led to worldwide outage fixed | Boeing shutdown may drag If workers demand higher | FPIs inject over Rs 16,000 crore this week |

Published 12:42 IST, August 26th 2024

Belgium's UCB to sell China neurology, allergy business for $680 million

The deal includes UCB's neurology portfolio comprising drugs like Keppra, Vimpat and Neupro, and anti-allergy medicines Zyrtec and Xyzal.

Companies
2 min read

Reported by: Thomson Reuters

Follow:

UCB to focus on innovation and partnerships

UCB to focus on innovation and partnerships | Image: Shutterstock

Listen to this article
2 min read

Advertisement

12:42 IST, August 26th 2024